Stockhead’s Fraser Palamara sits down with Island Pharmaceuticals (ASX:ILA)  CEO and managing director David Foster to get the short end of the long story on the company’s latest news.

The "toxic male technique" aims to breed mosquitoes that express venomous proteins in their semen, killing off females after ...

The dengue vaccine market is on track for robust growth, with increasing global awareness, governmental support, and ...

Female mosquitoes are targeted because only they bite and drink blood, thereby spreading diseases such as malaria and dengue ...

Mosquitoes looking to mate in Australia are about to have the worst sex of their lives – thanks to genetic modifications ...

SHELTON, CT / ACCESSWIRE / / Dr. Anil Diwan, President of NanoViricides, Inc. (NYSE American: NNVC ) (the "Company"), comments on the many viruses that could cause ...

Genetically engineered mosquitoes with toxic semen could be a new weapon against tropical disease, Australian scientists said ...

Climate change is one of the most serious global threats to the future of the world’s population. Its impact extends far and wide, from the economy to governance to the very health and well-being of ...

Island Pharmaceuticals has commenced its phase 2b clinical trial of lead drug ISLA-101 – for potentially treating dengue ...